pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3689a |
Genomic Coordinates | chr9: 134849487 - 134849564 |
Description | Homo sapiens miR-3689a stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3689a-5p | |||||||||||||||||||||
Sequence | 10| UGUGAUAUCAUGGUUCCUGGGA |31 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | FAM76A | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | family with sequence similarity 76 member A | ||||||||||||||||||||
Transcript | NM_001143912 | ||||||||||||||||||||
Other Transcripts | NM_001143913 , NM_001143914 , NM_001143915 , NM_152660 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on FAM76A | |||||||||||||||||||||
3'UTR of FAM76A (miRNA target sites are highlighted) |
>FAM76A|NM_001143912|3'UTR 1 CAGACCTCAAGGAGGCTCCCTAGCAACAGCAAATGGAGTTGTCCAGGGTTAGGGTTGGAGACCTGGCTGTTCTGTGGGAA 81 TTGCAAGCTTTCTTAAGAAATCTCTATTTTATTACAGTTATCCTTCTTTGTGCGATTGCAGTGGGCTGAATGGAAACACC 161 TGGTTTGTGCTGTGTTAGACTGCATGCTTGAGTGTTTGGGATTTCAAGCTCGCTCTCTTTCTCTCACTATTAGGACTTTT 241 CTTTTTCTTCTTCCTCTTCTCTCTATTTTGGTTCTATTCTTTTTTTTTCTTTTTTCTTTTTTTTTTTTTTTTTTTTTTTG 321 TGGTGGTCACTGCTCAGTGTAATGTGCAGAATGATTTGTTTTTTGTTTTTTTTTTTTTTTTTGGTCCTTCATTGCATCCT 401 GCCATACCCATGAGCAAACAGTTTGGCATTAATTATATATCACTGCCACCCTCTGAACTTTGAAAACTGCCATCTTCAGA 481 CTTGGTATAATGGAAGAGGCTTTCTCTCTCCAATAAACCTTTTGCTTCAGGGTATACTCTTCGGTTTTTTTCCAGATGTA 561 TTATGTATGAACTTTGTACTATGTATAGCCAGAGTTTTATTTATTTTTTAAAAAAGAAACTTTTTCTTGATAAAGGAATA 641 ATGGTGGTCTAGCTAGTTCTTGTAAAAGTGATGCCTCTTGAAAAAAAAACAGTCCTATTCACTAGCTTTTAGTAAAAGAA 721 TCAGATCTTTTCTTTCTTGTTACCTTGGAGTCTTAAAAACTGATTGCTAAGGTGAAACAATTCAATGCATAAGTATGGAG 801 CTAAGTGCCTTTTGGAGGATTTCTTGGAAGAGCATTTATGGAGATACTTAAGGGAGGTAGCAAAGATTTGAACCGTCTGT 881 CTTTTTAAGTAAGGGCAGAAAGCAAGGTTGTCCAGGTTGTACTGGACACTTCTCTCCCCACCCCTTTCCTGATTGTTTTA 961 TGTGATTGATTTTAAATTCTCACACTGCCACTTCTTTAAAAAATAAAATCCTTTATTTGCTTATATCAGTTGTCATACTG 1041 GGCTGCTGTCAGAGAATGTTTTTTTACATGAATGAACAGATTAAAAATGGAATAATATGGTCGGGTGCGGTGGCTCACGC 1121 CTGTAATACCAGCAATTTGGGAGGCCAAGGCGGGTGGATCATTTGAGGTTAGGAGTTTGAGACCATCCTGGCCAACATGG 1201 TAAAACCCCATCTGTACTAAAAAAATACAAAAATTAGCCGGGCCTGGTGGCATGCACCTGTAATCCCAGCTACCCAGGAG 1281 GCTGAGGCAGGAGAACTGCTCGAATCCCGGGAGGCAGAGGTTGCAATGAGCTGAAATCGCAACACTGCACTGCAGCCTGG 1361 GCAATGGAGTGAGACTCCGTCTCAAAAAAAAAAAAAAAAGGAATAATATTTGAACTACAGAGCATTTTTGGGGTCAGCAT 1441 GAGCTGCTCTAGTAAGGACTCTTGAGTCTGGGAAAAGTGGTATCACTATACCTTCTCCCCACTCCTCACCCACCCGAGCC 1521 CATACACTCCCTGCTTTTCATGGATATGTATTGAAAACAGGTGCTTCTCAGAAGCACTTTGCCTCAACCAGAGTTATGTA 1601 TGCCCTGCCTATCTTCCCTTCTTAACCCTGTAGGAATATGGATTTACTTTTCCAGGAAAGGGGATAGATTTACATTTCTA 1681 GGCATACTCTCAGGTCCTCTATGTGATGTTTGTGAAAGGAATTAGGGTGTGTCATGTGTGCCATGAAACAACAAAACCAA 1761 CTACCCTAGAATCATTTATGCAGGGGGTACTAGAGTTAGAAATAATAATGAGGGCAGATAACATTTGTACCTCAGTCTAC 1841 CAAAAAATTATAGTACTAAATTTAACTTCTAGGCGTTTCCTGGAAGCAGATGCTCTATAATTTGTGATAGCATTCTCATA 1921 AATGGAGTCCTACACATAATTGGACAGAGATGTGGAAATGGTGGTTTCCTTCTGATAAGGGATACAGTGGACCATGTCGC 2001 TTATATATCACCCTACTAGGGGATATAATTTTCCCTTCTAAGCAAGGGAAATGGCAGTGCTAAATAGTTTTGTAAAGTTT 2081 TTGAATGAGAAGCTTTTAGGTAAAGATAAACTGTCATAATATTTTTCAGATGCATTTGCATTGACTATGGGAGAAAAATT 2161 AGGGGGAAATGACAGTCATGGTGTTTTTTTTTAATTTTAAGGACTGAAATTCTGTTACATGATGTATGACAATATAAAAA 2241 CATACTTAGTTTTATACTAAATCTTTTTTTAAGGTCTTGGCATTTAATATAAAGCAAATTCACACGTTTTCTAACTTTCC 2321 ATAAGTTCCAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | EF3D-AGO2 |
Disease | MIMAT0018117 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1020021. RNA binding protein: AGO2. Condition:EBV B95-8-infected
... - Skalsky RL; Corcoran DL; Gottwein E; Frank et al., 2012, PLoS pathogens. |
Article |
- Skalsky RL; Corcoran DL; Gottwein E; Frank et al. - PLoS pathogens, 2012
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus linked to a number of B cell cancers and lymphoproliferative disorders. During latent infection, EBV expresses 25 viral pre-microRNAs (miRNAs) and induces the expression of specific host miRNAs, such as miR-155 and miR-21, which potentially play a role in viral oncogenesis. To date, only a limited number of EBV miRNA targets have been identified; thus, the role of EBV miRNAs in viral pathogenesis and/or lymphomagenesis is not well defined. Here, we used photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) combined with deep sequencing and computational analysis to comprehensively examine the viral and cellular miRNA targetome in EBV strain B95-8-infected lymphoblastoid cell lines (LCLs). We identified 7,827 miRNA-interaction sites in 3,492 cellular 3'UTRs. 531 of these sites contained seed matches to viral miRNAs. 24 PAR-CLIP-identified miRNA:3'UTR interactions were confirmed by reporter assays. Our results reveal that EBV miRNAs predominantly target cellular transcripts during latent infection, thereby manipulating the host environment. Furthermore, targets of EBV miRNAs are involved in multiple cellular processes that are directly relevant to viral infection, including innate immunity, cell survival, and cell proliferation. Finally, we present evidence that myc-regulated host miRNAs from the miR-17/92 cluster can regulate latent viral gene expression. This comprehensive survey of the miRNA targetome in EBV-infected B cells represents a key step towards defining the functions of EBV-encoded miRNAs, and potentially, identifying novel therapeutic targets for EBV-associated malignancies.
LinkOut: [PMID: 22291592]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_152660 | 3UTR | AAAUGGAGUCCUACACAUAAUUGGACAGAGAUGUGGAAAUGGUGGUUUCCUUCUGAUAAGGGAUACAGUGGACCAUGUCGCUUAUAUAUCACCCUACUAGGGGAUAUAAUUUUCCCUUCUAAGCAAGGGAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_152660 | 3UTR | CAGAGAUGUGGAAAUGGUGGUUUCCUUCUGAUAAGGGAUACAGUGGACCAUGUCGCUUAUAUAUCACCCUACUAGGGGAUAUAAUUUUCCCUUCUAAGCAAGGGAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_152660 | 3UTR | AUAAAUGGAGUCCUACACAUAAUUGGACAGAGAUGUGGAAAUGGUGGUUUCCUUCUGAUAAGGGAUACAGUGGACCAUGUCGCUUAUAUAUCACCCUACUAGGGGAUAUAAUUUUCCCUUCUAAGCAAGGGAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_152660 | 3UTR | GGACAGAGAUGUGGAAAUGGUGGUUUCCUUCUGAUAAGGGAUACAGUGGACCAUGUCGCUUAUAUAUCACCCUACUAGGGGAUAUAAUUUUCCCUUCUAAGCAAGGGAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_152660 | 3UTR | UUUCCUUCUGAUAAGGGAUACAGUGGACCAUGUCGCUUAUAUAUCACCCUACUAGGGGAUAUAAUUUUCCCUUCUAAGCAAGGGAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_001143915 | 3UTR | UCUCAUAAAUGGAGUCCUACACAUAAUUGGACAGAGAUGUGGAAAUGGUGGUUUCCUUCUGAUAAGGGAUACAGUGGACCAUGUCGCUUAUAUAUCACCCUACUAGGGGAUAUAAUUUUCCCUUCUAAGCAAGGGAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM1020021 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | EF3D-AGO2 / EBV B95-8-infected, 4-thiouridine, RNase T1 |
Location of target site | ENST00000373954.6 | 3UTR | UUGGCAUUAAUUAUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22291592 / GSE41437 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
45 hsa-miR-3689a-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT112230 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT188656 | FAM76A | family with sequence similarity 76 member A | 2 | 2 | ||||||||
MIRT200911 | ZNF264 | zinc finger protein 264 | 2 | 4 | ||||||||
MIRT210595 | KBTBD8 | kelch repeat and BTB domain containing 8 | 2 | 6 | ||||||||
MIRT299207 | CSRNP3 | cysteine and serine rich nuclear protein 3 | 2 | 2 | ||||||||
MIRT317524 | SLC39A7 | solute carrier family 39 member 7 | 2 | 2 | ||||||||
MIRT355849 | SGMS2 | sphingomyelin synthase 2 | 2 | 4 | ||||||||
MIRT443052 | THRB | thyroid hormone receptor beta | 2 | 2 | ||||||||
MIRT446631 | SDC3 | syndecan 3 | 2 | 2 | ||||||||
MIRT449409 | TRIM5 | tripartite motif containing 5 | 2 | 2 | ||||||||
MIRT463561 | ZBTB39 | zinc finger and BTB domain containing 39 | 2 | 6 | ||||||||
MIRT465704 | TNFAIP1 | TNF alpha induced protein 1 | 2 | 2 | ||||||||
MIRT472688 | MYCBP | MYC binding protein | 2 | 4 | ||||||||
MIRT493287 | LNPEP | leucyl and cystinyl aminopeptidase | 2 | 2 | ||||||||
MIRT499338 | RAB25 | RAB25, member RAS oncogene family | 2 | 2 | ||||||||
MIRT501723 | OVOL1 | ovo like transcriptional repressor 1 | 2 | 2 | ||||||||
MIRT507977 | BCL2L13 | BCL2 like 13 | 2 | 4 | ||||||||
MIRT511811 | HDGF | heparin binding growth factor | 2 | 6 | ||||||||
MIRT516711 | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 2 | 4 | ||||||||
MIRT527853 | SMOC1 | SPARC related modular calcium binding 1 | 2 | 2 | ||||||||
MIRT531286 | SLC7A7 | solute carrier family 7 member 7 | 2 | 2 | ||||||||
MIRT531894 | INVS | inversin | 2 | 8 | ||||||||
MIRT536807 | HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 2 | 2 | ||||||||
MIRT537807 | EFNB2 | ephrin B2 | 2 | 4 | ||||||||
MIRT544335 | LPGAT1 | lysophosphatidylglycerol acyltransferase 1 | 2 | 2 | ||||||||
MIRT547142 | PGM3 | phosphoglucomutase 3 | 2 | 2 | ||||||||
MIRT547429 | MED4 | mediator complex subunit 4 | 2 | 2 | ||||||||
MIRT563354 | ZNF181 | zinc finger protein 181 | 2 | 2 | ||||||||
MIRT564849 | ZBED3 | zinc finger BED-type containing 3 | 2 | 2 | ||||||||
MIRT566426 | PIGA | phosphatidylinositol glycan anchor biosynthesis class A | 2 | 2 | ||||||||
MIRT572512 | KIAA0232 | KIAA0232 | 2 | 2 | ||||||||
MIRT574682 | HNRNPA3 | heterogeneous nuclear ribonucleoprotein A3 | 2 | 2 | ||||||||
MIRT608820 | ONECUT3 | one cut homeobox 3 | 2 | 6 | ||||||||
MIRT608886 | CLIC6 | chloride intracellular channel 6 | 2 | 2 | ||||||||
MIRT608959 | GIMAP1 | GTPase, IMAP family member 1 | 2 | 4 | ||||||||
MIRT609012 | HPS3 | HPS3, biogenesis of lysosomal organelles complex 2 subunit 1 | 2 | 2 | ||||||||
MIRT641431 | SCUBE3 | signal peptide, CUB domain and EGF like domain containing 3 | 2 | 2 | ||||||||
MIRT661841 | ZNF587B | zinc finger protein 587B | 2 | 2 | ||||||||
MIRT690651 | RPF2 | ribosome production factor 2 homolog | 2 | 2 | ||||||||
MIRT704619 | CLIP1 | CAP-Gly domain containing linker protein 1 | 2 | 2 | ||||||||
MIRT708714 | PTPLAD2 | 3-hydroxyacyl-CoA dehydratase 4 | 1 | 1 | ||||||||
MIRT710663 | CSTF2T | cleavage stimulation factor subunit 2 tau variant | 2 | 2 | ||||||||
MIRT711260 | TPCN2 | two pore segment channel 2 | 2 | 2 | ||||||||
MIRT714649 | FSTL1 | follistatin like 1 | 2 | 2 | ||||||||
MIRT718518 | COL19A1 | collagen type XIX alpha 1 chain | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|